BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

285 related articles for article (PubMed ID: 16217027)

  • 1. Crystal structures of oxidized and reduced mitochondrial thioredoxin reductase provide molecular details of the reaction mechanism.
    Biterova EI; Turanov AA; Gladyshev VN; Barycki JJ
    Proc Natl Acad Sci U S A; 2005 Oct; 102(42):15018-23. PubMed ID: 16217027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Crystal structure of Escherichia coli thioredoxin reductase refined at 2 A resolution. Implications for a large conformational change during catalysis.
    Waksman G; Krishna TS; Williams CH; Kuriyan J
    J Mol Biol; 1994 Feb; 236(3):800-16. PubMed ID: 8114095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Three-dimensional structure of a mammalian thioredoxin reductase: implications for mechanism and evolution of a selenocysteine-dependent enzyme.
    Sandalova T; Zhong L; Lindqvist Y; Holmgren A; Schneider G
    Proc Natl Acad Sci U S A; 2001 Aug; 98(17):9533-8. PubMed ID: 11481439
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A mechanistic investigation of the C-terminal redox motif of thioredoxin reductase from Plasmodium falciparum.
    Snider GW; Dustin CM; Ruggles EL; Hondal RJ
    Biochemistry; 2014 Jan; 53(3):601-9. PubMed ID: 24400600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The structure of human thioredoxin reductase 1 provides insights into C-terminal rearrangements during catalysis.
    Fritz-Wolf K; Urig S; Becker K
    J Mol Biol; 2007 Jun; 370(1):116-27. PubMed ID: 17512005
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Structure and mechanism of mammalian thioredoxin reductase: the active site is a redox-active selenolthiol/selenenylsulfide formed from the conserved cysteine-selenocysteine sequence.
    Zhong L; Arnér ES; Holmgren A
    Proc Natl Acad Sci U S A; 2000 May; 97(11):5854-9. PubMed ID: 10801974
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High-resolution structures of oxidized and reduced thioredoxin reductase from Helicobacter pylori.
    Gustafsson TN; Sandalova T; Lu J; Holmgren A; Schneider G
    Acta Crystallogr D Biol Crystallogr; 2007 Jul; 63(Pt 7):833-43. PubMed ID: 17582174
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Crystal structure of reduced thioredoxin reductase from Escherichia coli: structural flexibility in the isoalloxazine ring of the flavin adenine dinucleotide cofactor.
    Lennon BW; Williams CH; Ludwig ML
    Protein Sci; 1999 Nov; 8(11):2366-79. PubMed ID: 10595539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The mechanism of high Mr thioredoxin reductase from Drosophila melanogaster.
    Bauer H; Massey V; Arscott LD; Schirmer RH; Ballou DP; Williams CH
    J Biol Chem; 2003 Aug; 278(35):33020-8. PubMed ID: 12816954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Twists in catalysis: alternating conformations of Escherichia coli thioredoxin reductase.
    Lennon BW; Williams CH; Ludwig ML
    Science; 2000 Aug; 289(5482):1190-4. PubMed ID: 10947986
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thioredoxin reductase is irreversibly modified by curcumin: a novel molecular mechanism for its anticancer activity.
    Fang J; Lu J; Holmgren A
    J Biol Chem; 2005 Jul; 280(26):25284-90. PubMed ID: 15879598
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The thioredoxin antioxidant system.
    Lu J; Holmgren A
    Free Radic Biol Med; 2014 Jan; 66():75-87. PubMed ID: 23899494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crystal structure of the Plasmodium falciparum thioredoxin reductase-thioredoxin complex.
    Fritz-Wolf K; Jortzik E; Stumpf M; Preuss J; Iozef R; Rahlfs S; Becker K
    J Mol Biol; 2013 Sep; 425(18):3446-60. PubMed ID: 23845423
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mammalian thioredoxin reductase: oxidation of the C-terminal cysteine/selenocysteine active site forms a thioselenide, and replacement of selenium with sulfur markedly reduces catalytic activity.
    Lee SR; Bar-Noy S; Kwon J; Levine RL; Stadtman TC; Rhee SG
    Proc Natl Acad Sci U S A; 2000 Mar; 97(6):2521-6. PubMed ID: 10688911
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thioredoxin reductase from Plasmodium falciparum: evidence for interaction between the C-terminal cysteine residues and the active site disulfide-dithiol.
    Wang PF; Arscott LD; Gilberger TW; Müller S; Williams CH
    Biochemistry; 1999 Mar; 38(10):3187-96. PubMed ID: 10074374
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reductive half-reaction of thioredoxin reductase from Escherichia coli.
    Lennon BW; Williams CH
    Biochemistry; 1997 Aug; 36(31):9464-77. PubMed ID: 9235991
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human mitochondrial thioredoxin reductase reduces cytochrome c and confers resistance to complex III inhibition.
    Nalvarte I; Damdimopoulos AE; Spyrou G
    Free Radic Biol Med; 2004 May; 36(10):1270-8. PubMed ID: 15110392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism and structure of thioredoxin reductase from Escherichia coli.
    Williams CH
    FASEB J; 1995 Oct; 9(13):1267-76. PubMed ID: 7557016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crystal structure of Arabidopsis thaliana NADPH dependent thioredoxin reductase at 2.5 A resolution.
    Dai S; Saarinen M; Ramaswamy S; Meyer Y; Jacquot JP; Eklund H
    J Mol Biol; 1996 Dec; 264(5):1044-57. PubMed ID: 9000629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acetaminophen reactive intermediates target hepatic thioredoxin reductase.
    Jan YH; Heck DE; Dragomir AC; Gardner CR; Laskin DL; Laskin JD
    Chem Res Toxicol; 2014 May; 27(5):882-94. PubMed ID: 24661219
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.